Alternative splicing of human metabotropic glutamate receptor 3

Journal of Neurochemistry

Volumn 96, Issue 4, 2006, Pages 1139-1148

  Sartorius, Leah J ^a,b   Nagappan, Guhan ^c   Lipska, Barbara K ^b   Lu, Bai ^b,c   Sei, Yoshitatsu ^b   Ren Patterson, Renee ^b   Li, Zhen ^b   Weinberger, Daniel R ^b   Harrison, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Brain; Metabotropic glutamate receptor 3; mRNA; Post mortem; Schizophrenia

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; METABOTROPIC RECEPTOR 3;

ADULT; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; B LYMPHOBLAST; BRAIN TISSUE; CADAVER; CELL STRAIN BHK; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MENTAL DISEASE; NERVE CELL CULTURE; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADULT; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CRICETINAE; DNA PRIMERS; FEMALE; HUMANS; KIDNEY; MALE; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; TRANSCRIPTION, GENETIC; TRANSFECTION;

ANIMALIA;

EID: 33645109172     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03609.x     Document Type: Article

References (34)

1. Baptista MA. Martin-Fardon R. Weiss F. 2004 Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer JNeurosci 24 4723 4727
2. Battaglia G. Bruno V. Ngomba RT. Di Grezia R. Copani A. Nicoletti F. 1998 Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death EurJPharm 356 271 274
3. Chen Q. He G. Chen Q. Wu S. Xu Y. Feng G. Li Y. Wang L. He L. 2005 A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population SchizophrRes 73 21 26
4. Ciccarelli R. Di Iorio P. Bruno V. Battaglia G. D'Alimonte I. D'Onofrio M. Nicoletti F. Caciagli F. 1999 Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes Glia 27 275 281
5. Colotta F. Dower SK. Sims JE. Mantovani A. 1994 The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1 ImmunolToday 15 562 566
6. Conn PJ. Pin JP. 1997 Pharmacology and functions of metabotropic glutamate receptors AnnuRevPharmacolToxicol 37 205 237
7. East SJ. Hill MP. Brotchie JM. 1995 Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes EurJPharmacol 277 117 121
8. Egan MF. Straub RE. Goldberg TE. et al. q20 2004 Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia ProcNatl AcadSciUSA 101 12 604 12 609
9. Folbergrova J. Haugvicova R. Mares P. 2001 Attenuation of seizures induced by homocysteic acid in immature rats by metabotropic glutamate group II and group III receptor agonists Brain Res 908 120 129
10. Frischmeyer PA. Dietz HC. 1999 Nonsense-mediated mRNA decay in health and disease HumMolGenet 8 1893 1900
11. Fujii Y. Shibata H. Kikuta R. et al. q21 2003 Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia PsychiatrGenet 13 71 76
12. Javitt DC. 2004 Glutamate as a therapeutic target in psychiatric disorders MolPsychiatry 9 979
13. Krystal JH. Abi-Saab W. Perry E. et al. q22 2005 Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects Psychopharmacology 179 303 309
14. Lejeune F. Maquat LE. 2005 Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells CurrOpinCell Biol 17 309 315
15. Lovinger DM. McCool BA. 1995 Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3 JNeurophysiol 73 1076 1083
16. Marti SB. Cichon S. Propping P. Nöthen M. 2002 Metabotropic glutamate receptor 3 (GRM3) gene variation is not associated with schizophrenia or bipolar affective disorder in the German population AmJMedGen 114 46 50
17. Moghaddam B. Adams BW. 1998 Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats [comment] Science 281 1349 1352
18. Murray TK. Messenger MJ. Ward MA. Woodhouse S. Osborne DJ. Duty S. O'Neill MJ. 2002 Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease PharmacolBiochemBehav 73 455 466
19. Norton NWH. Dwyer S. Ivanov D. Preece AC. Gerrish A. Williams NM. Yerassimou P. Zammit S. O'Donovan MC. Owen MJ. 2005 No evidence for association between polymorphisms in GRM3 and schizophrenia BMC Psychiatry 5 23
20. Olszewski RT. Bukhari N. Zhou J. et al. q23 2004 NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR JNeurochem 89 876 885
21. Petralia RS. Wang YX. Niedzielski AS. Wenthold RJ. 1996 The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 949 976
22. Pin JP. Duvoisin R. 1995 The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1 26
23. Pressman S. Rotter J I. 1991 Epstein-Barr virus transformation of cryopreserved lymphocytes: prolonged experience with technique Am. J. Hum. Genet. 49 467
24. Romano C. Miller JK. Hyrc K. Dikranian S. Mennerick S. Takeuchi Y. Goldberg MP. O'Malley KL. 2001 Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization MolPharmacol 59 46 53
25. Schoepp DD. Wright RA. Levine LR. Gaydos B. Potter WZ. 2003 LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress Stress 6 189 197
26. Swanson CJ. Perry KW. Schoepp DD. 2004 The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex JNeurochem 88 194 202
27. Swanson CJ. Bures M. Johnson MP. Linden AM. Monn JA. Schoepp DD. 2005 Metabotropic glutamate receptors as novel targets for anxiety and stress disorders NatRevDrug Discov 4 131 144
28. Tsuji Y. Shimada Y. Takeshita T. et al. q24 2000 Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1 JBiolChem 275 28 144 28 151
29. Varney MA. Gereau RWT. 2002 Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics CurrDrug Targets CNS NeurolDisord 1 283 296
30. Wroblewska B. Wroblewski JT. Pshenichkin S. Surin A. Sullivan SE. Neale JH. 1997 N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells JNeurochem 69 174 181
31. Yao Y. Koo JC. Wells JW. Hampson DR. 2004 Expression of a truncated secreted form of the mGluR3 subtype of metabotropic glutamate receptor BiochemBiophysResCommun 319 622 628
32. Yeo GW. Van Nostrand E. Holste D. Poggio T. Burge CB. 2005 Identification and analysis of alternative splicing events conserved in human and mouse ProcNatl AcadSciUSA 102 2850 2855
33. Yoshino M. Sawada S. Yamamoto C. Kamiya H. 1996 A metabotropic glutamate receptor agonist DCG-IV suppresses synaptic transmission at mossy fiber pathway of the guinea pig hippocampus NeurosciLett 207 70 72
34. Zwienenberg M. Gong QZ. Berman RF. Muizelaar JP. Lyeth BG. 2001 The effect of groups II and III metabotropic glutamate receptor activation on neuronal injury in a rodent model of traumatic brain injury Neurosurgery 48 1119 1126 ; discussion 1126-1117.